Enrollment completed in both Phase 3 chronic spontaneous urticaria global registration studies (EMBARQ-CSU 1 and 2) six ...

MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the fourth ...

Water intake can boost metabolism and control appetite to help with weight loss. Replacing high-calorie drinks with water ...

Q4 2025 Earnings Call February 24, 2026 5:00 PM ESTCompany ParticipantsTryn Stimart - Chief Legal Officer, CCO, ...

Enrollment completed six months ahead of guidance, driven by significant unmet need for better treatments in CSUTopline data expected Q4 2026BLA ...

Wildlife Expansion, Reintroduction Programs, and Changing Predator Behavior Create New Challenges for Rural Properties ...

Today, Jazz Pharmaceuticals reported its Fourth Quarter and Full Year 2025 Financial Results. The slide presentation accompanying this webcast is available on the Investors section of our website, ...

Students will be sorted into several tiers based on disability, income and other factors.

Immunocore reports fourth quarter and full year 2025 financial results and provides a business update KIMMTRAK ...

Results in a population of 278 patients affirm statistically significant mortality reductionsBenefits observed across severity groups and in ...

An informational overview of Ivím Health's compounded semaglutide and tirzepatide telehealth program, including GLP-1 ID cost breakdown, weekly provider check-in structure, clinical claims analysis, a ...

Research and Development (R&D) expenses: R&D expenses totaled $44.6 million for the fourth quarter of 2025 and $50.5 million ...